Martin Gutierrez

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand et al. · Journal of Clinical Oncology · 2016 · 1K citations · Full text

Medicine, Hematology, Oncology +17

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Neal Ready, Matthew D. Hellmann, Mark M. Awad et al. · Journal of Clinical Oncology · 2019 · 596 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Highly effective treatment of acquired immunodeficiency syndrome–related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

Richard F. Little, Stefania Pittaluga, Nicole Grant et al. · Blood · 2003 · 355 citations

Life Sciences, Immunology, Oncology +12

Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy

Wyndham H. Wilson, Michael L. Grossbard, Stefania Pittaluga et al. · Blood · 2002 · 330 citations

Medicine, Oncology, Pharmacology +17

Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities

Martin Gutierrez, Kelly Choi, Richard B. Lanman et al. · Clinical Lung Cancer · 2017 · 210 citations

Medicine, Molecular Genetics, Oncology +17